- Current status
- AHSCT is a standard of care of RRMS
- Wykłady na kursie specjalizacyjnym – transplantologia
- AHSCT is better choice than DMDs in MS as a treatment of cases progressing after first line treatment – multicenter randomised trial.
- CPX-351 (Vyxeos) – new drug that improves treatment in older patients with secondary AML
Monthly Archives: September 2010
I work each day to put all links that I talk about in my seminars for students. I am thinking about publishing a “Guide to painless or almost painless bone marrow biopsy” – this would be a great thing for … Continue reading